Automated cell-based assay for screening of aquaporin inhibitors.
Aquaporins form water channels that play major roles in a variety of physiological processes so that altered expression or function may underlie pathological conditions. In order to identify compounds that modulate aquaporin function, we have implemented a functional assay based on rapid measurement of osmotically induced cell volume changes to screen several libraries of diverse drugs. The time course of fluorescence changes in calcein-loaded cells was analyzed during an osmotic challenge using a 96-multiwell fluorescence plate reader. This system was validated using astrocyte primary cultures and fibroblasts that strongly express endogenous AQP4 and AQP1 proteins, respectively, as well as AQP4-transfected cells. We screened 3575 compounds, including 418 FDA-approved and commercially available drugs, for their effect on AQP-mediated water transport. Primary screening yielded 10 compounds that affected water transport activity in both astrocytes and AQP4-transfected cells and 42 compounds that altered cell volume regulation in astrocytes. Selected drugs were then analyzed on AQP1-expressing erythrocytes and AQP4-expressing membrane vesicles by stopped-flow light scattering. Four molecules of the National Cancer Institute's chemical library (NSC164914, NSC670229, NSC168597, NSC301460) were identified that differentially affected both AQP4 and AQP1 mediated water transport, with EC50 values between 20 and 50 microM. This fluorescence microplate reader-based assay may, thus, provide a platform for high-throughput screening which, when coupled to a secondary evaluation to confirm target specificity, should allow discovery of AQP-specific compounds for novel therapeutic strategies in the treatment of water balance disorders.
Mola
Maria Grazia
MG
Department of General and Environmental Physiology and Centre of Excellence in Comparative Genomics (CEGBA), University of Bari, I-70126 Bari, Italy.
Nicchia
Grazia Paola
GP
Svelto
Maria
M
Spray
David C
DC
Frigeri
Antonio
A
D000818:Animals; D051398:Aquaporin 1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051401:Aquaporin 4 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D001253:Astrocytes / Q000378:metabolism; D001681:Biological Assay / Q000379:methods*; D002478:Cells, Cultured; D004912:Erythrocytes / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D005452:Fluoresceins / Q000737:chemistry; D051379:Mice; D009995:Osmosis; D051381:Rats; D054852:Small Molecule Libraries; D014162:Transfection
D051401:Aquaporin 4; D005452:Fluoresceins; D054852:Small Molecule Libraries; D051398:Aquaporin 1; C007740:fluorexon
J Biomol Screen. 1999;4(2):67-73
10838414
Glia. 2000 Jul;31(1):29-38
10816604
J Mol Evol. 2001 May;52(5):391-404
11443343
Bioorg Med Chem. 2009 Jan 1;17(1):418-24
18178093
Pflugers Arch. 2008 May;456(2):285-92
18043939
Am J Physiol. 1999 Oct;277(4):C823-32
10516112
Bioorg Med Chem. 2008 Aug 1;16(15):7489-93
18572411
FEBS Lett. 2002 Nov 20;531(3):443-7
12435590
Mol Cell Biochem. 1991 May 29-Jun 12;104(1-2):51-6
1656196
J Biol Chem. 2006 May 19;281(20):14207-14
16551622
Expert Rev Mol Med. 2008 May 16;10:e13
18482462
FEBS Lett. 2006 Sep 18;580(21):5059-66
16949586
FEBS Lett. 2006 Dec 11;580(28-29):6679-84
17126329
Clin Lab Sci. 2006 Spring;19(2):80-9
16749244
Glia. 2009 Oct;57(13):1363-73
19229993
Neuroscience. 2004;129(4):905-13
15561407
J Membr Biol. 2000 Jan 15;173(2):73-87
10630923
Anal Biochem. 2006 Mar 15;350(2):165-70
16480680
J Biol Chem. 1992 Sep 15;267(26):18267-9
1526967
J Endocrinol. 1972 Oct;55(1):1-9
4350080
Am J Physiol Renal Physiol. 2004 Sep;287(3):F501-11
15149973
J Physiol. 2002 Jul 1;542(Pt 1):3-16
12096044
Curr Pharm Des. 2007;13(23):2421-7
17692010
Glia. 2008 Dec;56(16):1755-66
18649401
Am J Physiol. 1991 Jan;260(1 Pt 1):C113-21
1702933
Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6467-71
1378628
Neuroscience. 2005;136(1):105-14
16203098
J Biol Chem. 2006 Jun 2;281(22):15485-95
16571723
Oncol Rep. 2008 Jun;19(6):1511-6
18497958
Cell Biochem Biophys. 2008;51(1):21-32
18365146
Ann Med. 2002;34(3):192-200
12173689
Acta Pharmacol Sin. 2004 Jan;25(1):90-7
14704128
Neuroscience. 2004;129(4):983-91
15561413
Z Naturforsch C J Biosci. 1997 Jan-Feb;52(1-2):65-9
9090068
FASEB J. 2004 May;18(7):905-7
15033928
FASEB J. 2003 Aug;17(11):1508-10
12824287
BMC Physiol. 2002;2:4
11914159
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1270-3
17178220
Am J Physiol Cell Physiol. 2004 Feb;286(2):C426-32
14576087
Prog Brain Res. 2008;170:589-601
18655912
J Biol Chem. 2002 Sep 27;277(39):36782-6
12133842
Am J Physiol Renal Physiol. 2008 Mar;294(3):F582-90
18094031
J Clin Endocrinol Metab. 2007 Sep;92(9):3640-5
17566090
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10908-12
8855281
Rev Physiol Biochem Pharmacol. 2005;155:31-55
16091927
Mol Pharmacol. 2000 May;57(5):1021-6
10779387
FASEB J. 2005 Oct;19(12):1674-6
16103109
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13609-14
14597700
Biochim Biophys Acta. 1990 Dec 14;1030(2):203-10
2175653
Am J Physiol. 1994 Jan;266(1 Pt 1):C165-71
8304413